Dual-track pathway of bladder carcinogenesis: practical implications
- PMID: 16740038
- DOI: 10.5858/2006-130-844-DPOBCP
Dual-track pathway of bladder carcinogenesis: practical implications
Abstract
Context: The concept of a dual-track pathway in bladder carcinogenesis postulates that bladder cancer develops via 2 distinct but somewhat overlapping pathways, termed the papillary and nonpapillary. Approximately 80% of bladder carcinomas consist of superficial exophytic papillary lesions that originate from urothelial hyperplasia. These typically low-grade papillary tumors may recur, but they rarely invade the bladder wall or metastasize. The remaining 15% to 20% of tumors represent high-grade solid nonpapillary bladder carcinoma, which arise from high-grade intraurothelial neoplasia. These tumors aggressively invade the bladder wall and have a high propensity for distant metastasis.
Objective: To summarize the scientific literature and provide a clinicopathologic review of the dual-track concept of bladder carcinogenesis with its important implications.
Data sources: Relevant articles indexed in PubMed (National Library of Medicine) between 1974 and 2005.
Conclusions: Although the characteristics of papillary and nonpapillary tumors are quite dissimilar, current evidence implies that both forms of bladder cancer start as a clinically occult clonal expansion of preneoplastic lesions that occupy large areas of the bladder mucosa.
Similar articles
-
Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia.Semin Diagn Pathol. 1997 May;14(2):84-97. Semin Diagn Pathol. 1997. PMID: 9179970 Review.
-
The origins of bladder cancer.Lab Invest. 2008 Jul;88(7):686-93. doi: 10.1038/labinvest.2008.48. Epub 2008 May 12. Lab Invest. 2008. PMID: 18475256
-
Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.Am J Surg Pathol. 2006 Jul;30(7):883-91. doi: 10.1097/01.pas.0000213283.20166.5a. Am J Surg Pathol. 2006. PMID: 16819332
-
[So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].Ann Pathol. 2003 Feb;23(1):35-45. Ann Pathol. 2003. PMID: 12743498 Review. French.
-
Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c. Am J Surg Pathol. 2012. PMID: 22301493 Review.
Cited by
-
Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).Expert Rev Mol Med. 2010 Mar 25;12:e10. doi: 10.1017/S1462399410001407. Expert Rev Mol Med. 2010. PMID: 20334706 Free PMC article. Review.
-
A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer.Oncol Lett. 2020 Jan;19(1):476-486. doi: 10.3892/ol.2019.11123. Epub 2019 Nov 19. Oncol Lett. 2020. PMID: 31897161 Free PMC article.
-
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.Lab Invest. 2008 Jul;88(7):694-721. doi: 10.1038/labinvest.2008.27. Epub 2008 May 5. Lab Invest. 2008. PMID: 18458673 Free PMC article.
-
Assessment of Luminal and Basal Phenotypes in Bladder Cancer.Sci Rep. 2020 Jun 16;10(1):9743. doi: 10.1038/s41598-020-66747-7. Sci Rep. 2020. PMID: 32546765 Free PMC article.
-
Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.Br J Pharmacol. 2010 Aug;160(8):2008-27. doi: 10.1111/j.1476-5381.2010.00861.x. Br J Pharmacol. 2010. PMID: 20649598 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical